| Literature DB >> 27355833 |
Matthew J LaMarche, Jennifer A Leeds1, Jason Brewer, Karl Dean, Jian Ding, Joanne Dzink-Fox1, Gabe Gamber, Akash Jain, Ryan Kerrigan, Philipp Krastel2, Kwangho Lee, Franco Lombardo, David McKenney1, Georg Neckermann1, Colin Osborne1, Deborah Palestrant, Michael A Patane, Elin M Rann, Zachary Robinson, Esther Schmitt2, Travis Stams, Stacey Tiamfook1, Donghui Yu1, Lewis Whitehead.
Abstract
Synthetic studies of the antimicrobial secondary metabolite thiomuracin A (1) provided access to analogues in the Northern region (C2-C10). Selective hydrolysis of the C10 amide of lead compound 2 and subsequent derivatization led to novel carbon- and nitrogen-linked analogues (e.g., 3) which improved antibacterial potency across a panel of Gram-positive organisms. In addition, congeners with improved physicochemical properties were identified which proved efficacious in murine sepsis and hamster C. difficile models of disease. Optimal efficacy in the hamster model of C. difficile was achieved with compounds that possessed both potent antibacterial activity and high aqueous solubility.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27355833 DOI: 10.1021/acs.jmedchem.6b00726
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446